SEM Stock Financial Analysis - Select Medical Holdings Corporation (NYSE) Stock

Select Medical Holdings Corporation
US ˙ NYSE ˙ US81619Q1058

Overview
Select Medical Holdings Corporation, headquartered in the United States, operates extensively in the healthcare sector, specifically focusing on critical illness recovery hospitals, rehabilitation centers, outpatient rehabilitation clinics, and occupational health services. Established in 1996, the company has grown to manage approximately 100 critical illness recovery hospitals and 20 rehabilitation hospitals through its segments, supported by a network of over 1,800 outpatient rehabilitation clinics nationwide. Select Medical also extends into occupational health through its Concentra subsidiary, which runs approximately 520 medical centers. This extensive reach underscores its pivotal role in providing specialized clinical care and rehabilitation services, positioning it as a significant player in the U.S. healthcare system.
Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income
  • The revenue for Select Medical Holdings Corporation as of June 30, 2025 is 5,276.90 MM.
  • The operating income for Select Medical Holdings Corporation as of June 30, 2025 is 275.27 MM.
  • The net income for Select Medical Holdings Corporation as of June 30, 2025 is 136.83 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-06-30 5,276.90 275.27 136.83
2025-03-31 5,219.07 262.59 173.82
2024-12-31 5,187.10 268.31 214.04
2024-09-30 4,184.95 160.08 276.36
2024-06-30 4,089.43 148.91 268.91
2024-03-31 4,482.21 234.25 269.58
2023-12-31 4,825.98 267.24 243.49
2023-09-30 6,586.66 527.25 224.73
2023-06-30 6,488.76 480.32 203.71
2023-03-31 6,398.97 426.95 180.68
2022-12-31 4,609.18 116.30 158.99
2022-09-30 6,311.89 360.53 181.35
2022-06-30 6,278.32 425.92 231.11
2022-03-31 6,257.60 505.96 340.80
2021-12-31 6,204.52 570.07 402.23
2021-09-30 6,105.20 629.54 429.64
2021-06-30 5,994.85 638.42 429.66
2021-03-31 5,663.54 517.07 316.42
2020-12-31 5,531.71 477.64 259.00
2020-09-30 5,445.80 462.87 213.79
Income Statement: EPS
  • The earnings per share basic for Select Medical Holdings Corporation as of June 30, 2025 is 1.08.
  • The earnings per share diluted for Select Medical Holdings Corporation as of June 30, 2025 is 1.08.
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-06-30 1.08 1.08
2025-03-31 1.37 1.37
2024-12-31 1.66
2024-09-30 2.23 2.23
2024-06-30 2.18 2.18
2024-03-31 2.18 2.18
2023-12-31 1.91
2023-09-30 1.76 1.76
2023-06-30 1.60 1.60
2023-03-31 1.42 1.42
2022-12-31 1.23
2022-09-30 1.39 1.39
2022-06-30 1.74 1.74
2022-03-31 2.54 2.54
2021-12-31 2.98
2021-09-30 3.18 3.19
2021-06-30 3.19 3.19
2021-03-31 2.35 2.35
2020-12-31 1.93
2020-09-30 1.59 1.59
Cash Flow: Operations, Investing, Financing
  • The cash from operating activities for Select Medical Holdings Corporation as of June 30, 2025 is 413.24 MM.
  • The cash from investing activities for Select Medical Holdings Corporation as of June 30, 2025 is -236.27 MM.
  • The cash from financing activities for Select Medical Holdings Corporation as of June 30, 2025 is -235.78 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-06-30 413.24 -236.27 -235.78
2025-03-31 581.10 -225.67 -394.83
2024-12-31 517.86 -231.01 -311.17
2024-09-30 571.87 -226.40 -231.44
2024-06-30 507.24 -244.33 -252.92
2024-03-31 463.93 -257.07 -197.94
2023-12-31 582.06 -268.48 -327.48
2023-09-30 415.16 -256.13 -189.82
2023-06-30 393.08 -248.12 -138.47
2023-03-31 329.93 -240.07 -137.04
2022-12-31 284.82 -226.34 -34.89
2022-09-30 211.53 -268.37 -582.92
2022-06-30 216.22 -282.44 -642.60
2022-03-31 167.68 -259.34 -527.73
2021-12-31 401.23 -256.59 -647.38
2021-09-30 669.42 -210.49 -350.74
2021-06-30 705.00 -123.04 -288.21
2021-03-31 1,223.88 -123.28 -423.49
2020-12-31 1,028.07 -115.35 -671.54
2020-09-30 999.18 -108.20 -387.14
Valuation Metrics : PE, PriceToBook, PriceToTBV
  • The p/book for Select Medical Holdings Corporation as of June 30, 2025 is 0.95.
  • The p/tbv for Select Medical Holdings Corporation as of June 30, 2025 is -4.89.
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-06-30 0.95 -4.89
2025-03-31 1.08 -4.95
2024-12-31 1.05 -1.55
2024-09-30 16.76 2.60 -2.14
2024-06-30 16.93 2.74 -2.10
2024-03-31 15.53 2.40 -1.67
2023-12-31 13.40 1.94 -1.31
2023-09-30 15.77 2.09 -1.40
2023-06-30 22.63 2.81 -1.72
2023-03-31 20.64 2.36
2022-12-31 2.31 -1.28
2022-09-30 2.07 -1.12
2022-06-30 2.19 -1.27
2022-03-31 7.98 2.35 -1.30
2021-12-31 9.18 1.98 -2.21
2021-09-30 11.33 2.47 -2.71
2021-06-30
2021-03-31 9.47 1.67 -1.51
2020-12-31 11.57 1.81 -1.42
2020-09-30 14.01 1.70 -1.50
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
  • The ebit/ev for Select Medical Holdings Corporation as of June 30, 2025 is 0.05.
  • The ebit (3y)/ev for Select Medical Holdings Corporation as of June 30, 2025 is 0.08.
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-06-30 0.05 0.08
2025-03-31 0.04 0.07
2024-12-31 0.08 0.06
2024-09-30 0.05 0.04
2024-06-30 0.05 0.05
2024-03-31 0.05 0.06
2023-12-31 0.05 0.07
2023-09-30 0.05 0.06
2023-06-30 0.04 0.06
2023-03-31 0.04 0.06
2022-12-31 0.04 0.06
2022-09-30 0.05 0.07
2022-06-30 0.07 0.07
2022-03-31 0.09 0.07
2021-12-31 0.10 0.06
2021-09-30 0.09 0.05
2021-06-30
2021-03-31 0.09 0.06
2020-12-31 0.07 0.05
2020-09-30 0.06 0.04
Management Effectiveness
  • The roa for Select Medical Holdings Corporation as of June 30, 2025 is 0.02.
  • The roe for Select Medical Holdings Corporation as of June 30, 2025 is 0.10.
  • The roic for Select Medical Holdings Corporation as of June 30, 2025 is 0.04.
  • The croic for Select Medical Holdings Corporation as of June 30, 2025 is -0.01.
  • The ocroic for Select Medical Holdings Corporation as of June 30, 2025 is 0.12.
Period End (TTM) ROA ROE ROIC CROIC OCROIC
2025-06-30 0.02 0.10 0.04 -0.01 0.12
2025-03-31 0.03 0.13 0.05 -0.01 0.11
2024-12-31 0.04 0.18 0.04 0.02 0.08
2024-09-30 0.03 0.17 0.04 0.00 0.08
2024-06-30 0.04 0.19 0.04 0.00 0.07
2024-03-31 0.03 0.18 0.04 -0.00 0.09
2023-12-31 0.03 0.16 0.03 -0.00 0.06
2023-09-30 0.03 0.15 0.03 0.00 0.06
2023-06-30 0.02 0.13 0.03 0.00 0.06
2023-03-31 0.02 0.11 0.03 -0.01 0.05
2022-12-31 0.02 0.09 0.03 -0.10 0.03
2022-09-30 0.03 0.12 0.03 -0.10 0.03
2022-06-30 0.04 0.17 0.04 -0.11 0.03
2022-03-31 0.05 0.22 0.05 -0.10 0.03
2021-12-31 0.06 0.26 0.07 -0.08 0.10
2021-09-30 0.06 0.24 0.07 0.02 0.11
2021-06-30 0.06 0.26 0.07 0.05 0.11
2021-03-31 0.04 0.20 0.05 0.11 0.19
2020-12-31 0.04 0.45 0.04 0.04 0.17
2020-09-30 0.03 0.11 0.03 0.08 0.16
Gross Margins
  • The gross margin for Select Medical Holdings Corporation as of June 30, 2025 is 0.19.
  • The net margin for Select Medical Holdings Corporation as of June 30, 2025 is 0.03.
  • The operating margin for Select Medical Holdings Corporation as of June 30, 2025 is 0.05.
Gross Margin
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Net Margin
The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
Operating Margin
The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) Gross Margin Net Margin Operating Margin
2025-06-30 0.19 0.03 0.05
2025-03-31 0.18 0.04 0.05
2024-12-31 0.20 0.04 0.09
2024-09-30 0.20 0.04 0.09
2024-06-30 0.22 0.04 0.09
2024-03-31 0.14 0.04 0.08
2023-12-31 0.23 0.03 0.08
2023-09-30 0.19 0.03 0.07
2023-06-30 0.19 0.03 0.07
2023-03-31 0.17 0.03 0.07
2022-12-31 0.17 0.03 0.06
2022-09-30 0.21 0.03 0.06
2022-06-30 0.19 0.04 0.05
2022-03-31 0.20 0.05 0.08
2021-12-31 0.22 0.06 0.09
2021-09-30 0.22 0.07 0.10
2021-06-30 0.22 0.07 0.11
2021-03-31 0.21 0.06 0.09
2020-12-31 0.05 0.09
2020-09-30 0.21 0.04 0.08
Identifiers and Descriptors
Central Index Key (CIK)1320414
Industry Groups
SIC 806 - Hospitals
Other Listings
DE:S24 €10.80
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista